Physician profile
Evelyn L Wright
NPI 1376777508
$1,658.09
in general payments reported to CMS, 2019-2025
19 companies · $494 in 2025
The $494 reported for 2025 was more than what 76% of Family Health providers received nationally (typical 2025 total: $209).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $321 · 2022: $283 · 2023: $257 · 2024: $304 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,054.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $557.43 | 2021-2025 | |
| Novo Nordisk INC | $267.68 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $227.24 | 2022-2025 | Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $109.02 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $67.47 | 2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $63.20 | 2023-2024 | |
| Axsome Therapeutics, INC. | $51.74 | 2025 | Auvelity |
| Lilly USA, LLC | $48.25 | 2021-2024 | Mounjaro |
| Pfizer INC. | $43.65 | 2021-2025 | |
| Medtronic, INC. | $41.93 | 2024 | Minimed 780g |
| Exact Sciences Corporation | $36.39 | 2023-2024 | Cologuard Collection Kit |
| Corcept Therapeutics | $34.89 | 2024-2025 | Korlym |
| Janssen Pharmaceuticals, INC | $24.47 | 2023 | Xarelto |
| Biohaven Pharmaceuticals, INC. | $22.65 | 2021 | |
| Insulet Corporation | $18.19 | 2025 | Omnipod |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $16.73 | 2023 | Accrufer |
| Viatris Specialty LLC | $14.14 | 2025 | Yupelri |
| Phathom Pharmaceuticals, INC. | $11.22 | 2025 | Voquezna |
| Genentech USA, INC. | $1.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evelyn Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.